VivaVision Biotech's FDA Meeting Outcome Paves Way for VVN461HD's Development in Uveitis Treatment VivaVision's innovative drug VVN461HD for uveitis treatment needs only one more clinical trial in the U.S. before its NDA submission, following FDA's positive feedback.

VivaVision Biotech's FDA Meeting Outcome Paves Way for VVN461HD's Development in Uveitis Treatment #China #VivaVision #Wenzhou #Uveitis #VVN461HD

Growth Forecast of the Cataract Surgery Complications Market Up to 2034 The cataract surgery complications market is set to see significant growth driven by new therapies, improved diagnostics, and increased awareness from 2025 to 2034.

Growth Forecast of the Cataract Surgery Complications Market Up to 2034 #None #VivaVision #cataract_surgery #Oculis

VivaVision Biotech Welcomes Renowned Ophthalmology Expert to Advisory Board VivaVision Biotech has announced the addition of renowned ophthalmologist Quan Dong Nguyen to its Scientific Advisory Board, enhancing its expertise.

VivaVision Biotech Welcomes Renowned Ophthalmology Expert to Advisory Board #China #VivaVision #Wenzhou #ophthalmology #Quan_Dong_Nguyen

VivaVision Biotech Receives Positive FDA Feedback for VVN461LD Trial in Eye Inflammation Treatment VivaVision Biotech has received encouraging preliminary comments from the FDA regarding its VVN461LD treatment for post-operative eye inflammation, simplifying the trial process.

VivaVision Biotech Receives Positive FDA Feedback for VVN461LD Trial in Eye Inflammation Treatment #China #FDA #VivaVision #Wenzhou #VVN461LD

VivaVision's VVN461 Shows Promising Results in Phase 2 Trial for Non-Infectious Anterior Uveitis Treatment VivaVision Biotech celebrates significant success with VVN461, revealing promising efficacy and safety results in treating Non-Infectious Anterior Uveitis in their Phase 2 trial.

VivaVision's VVN461 Shows Promising Results in Phase 2 Trial for Non-Infectious Anterior Uveitis Treatment #China #VivaVision #VVN461 #Wenzhou #NIAU

Fremont Street at the end of the night. From July 2024.
#fremontstreet #lasvegas #fabulouslasvegas #downtownlv #vivavision #circa #neondreams #vegaslife #binions #endofthenight

Viva Biotech's Portfolio Companies Showcase Promising Advances in Biotechnology Viva Biotech's portfolio companies, including TechnoDerma and VivaVision, have shared exciting updates, demonstrating significant progress in clinical trials and therapies aimed at various health conditions.

Viva Biotech's Portfolio Companies Showcase Promising Advances in Biotechnology #VivaVision #Viva_Biotech #Technoderma

VivaVision's VVN461 Shows Promising Results in Inflammation After Cataract Surgery VivaVision Biotech shares encouraging results from its Phase 2 trial of VVN461, a new treatment aimed at reducing inflammation post-cataract surgery, demonstrating significant efficacy and safety.

VivaVision's VVN461 Shows Promising Results in Inflammation After Cataract Surgery #China #VivaVision #VVN461 #cataract_surgery #Wenzhou